Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Gan & Lee Pharmaceuticals' GZR18 injection, a bi-weekly GLP-1 receptor agonist, has received FDA clearance for a Phase 2 trial.
Gan & Lee Pharmaceutical's subsidiary obtains FDA approval for Phase II clinical trials of GZR18 injection in the U.S.
Gan & Lee Pharmaceuticals announced positive Phase 1 results for its oral GLP-1 receptor agonist (RA) GZR18 tablets in healthy participants.